Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing androgen-estrogen balance with letrozole in testosterone-substituted hypogonadal men
2006-006925-26Phase 2Active
- Sponsor
- Rijnstate
- Start
- Jan 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of letrozole in hypogonadotropic hypogonadism (HH), sponsored by Rijnstate. Primary endpoint: Change in serum testosterone levels with letrozole add-on. Started Jan 2007; status: active.
02
Drugs
letrozole
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on 2006-006925-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006925-26.